Gene · 8553
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Candidate master microRNA regulator of arsenic-induced pancreatic beta cell impairment revealed by multi-omics analysis. | Arch Toxicol | 2022 | 35314868 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes and signaling pathways with Candida infection by bioinformatics analysis. | Eur J Med Res | 2022 | 35314002 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia. | Genes Dev | 2022 | 35301220 | PubTator, text mining | PubMed |
| A genome-wide association study of outcome from traumatic brain injury. | EBioMedicine | 2022 | 35301180 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. | Nat Commun | 2022 | 35296668 | PubTator, text mining | PubMed |
| Otto Aufranc Award: Identification of Key Molecular Players in the Progression of Hip Osteoarthritis Through Transcriptomes and Epigenetics. | J Arthroplasty | 2022 | 35288246 | PubTator, text mining | PubMed |
| P2RY14 downregulation in lung adenocarcinoma: a potential therapeutic target associated with immune infiltration. | J Thorac Dis | 2022 | 35280459 | PubTator, text mining | PubMed |
| ACE2-independent infection of T lymphocytes by SARS-CoV-2. | Signal Transduct Target Ther | 2022 | 35277473 | PubTator, text mining | PubMed |
| PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power. | Cancers (Basel) | 2022 | 35267575 | PubTator, text mining | PubMed |
| Escape from senescence: revisiting cancer therapeutic strategies. | Mol Cell Oncol | 2022 | 35252554 | PubTator, text mining | PubMed |
| Expression signature of the Leigh syndrome French-Canadian type. | Mol Genet Metab Rep | 2022 | 35242578 | PubTator, text mining | PubMed |
| TADreg: a versatile regression framework for TAD identification, differential analysis and rearranged 3D genome prediction. | BMC Bioinformatics | 2022 | 35236295 | PubTator, text mining | PubMed |
| A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates. | J Clin Transl Hepatol | 2022 | 35233377 | PubTator, text mining | PubMed |
| REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk. | J Immunol | 2022 | 35217585 | PubTator, text mining | PubMed |
| Monocyte Gene and Molecular Expression Profiles Suggest Distinct Effector and Regulatory Functions in Beninese HIV Highly Exposed Seronegative Female Commercial Sex Workers. | Viruses | 2022 | 35215954 | PubTator, text mining | PubMed |
| The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? | Front Immunol | 2022 | 35211123 | PubTator, text mining | PubMed |
| Unlocking the Memory Component of Alzheimer's Disease: Biological Processes and Pathways across Brain Regions. | Biomolecules | 2022 | 35204764 | PubTator, text mining | PubMed |
| BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy. | Cancer Immunol Res | 2022 | 35181783 | PubTator, text mining | PubMed |
| Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription. | J Exp Clin Cancer Res | 2022 | 35180863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8553/papers?page=25